Normal human
IgG contains naturally occurring anti-C3
antibodies (anti-C3 NAbs) that have been proposed to regulate
complement amplification. Here, we report a novel procedure for anti-C3 NAb purification. Pooled human
IgG was fractionated on a
DEAE column prior to affinity chromatography on
IgG and then on C3. Anti-C3 NAbs co-purified with anti-F(ab')2 NAbs. In a refined protocol,
IgG fractions were absorbed on Fc, F(ab')2, and C3, which allowed to isolate the directly accessible NAbs and to remove
IgG hinge-region-specific NAbs. Since a substantial fraction of total anti-C3 NAbs in whole
IgG pre-existed as complexes,
IgG that did not bind to the three affinity columns was treated with
urea and the affinity chromatography repeated to collect the dissociated NAbs. The
urea-accessible anti-F(ab')2 NAbs were rather pure but anti-C3 NAbs yet contained substantial amounts of anti-F(ab')2 NAbs. Anti-C3 NAbs showed up to 400-fold and anti-F(ab')2 NAbs, up to 30-fold enrichment as compared to pooled normal human
IgG. Anti-C3 NAb preparations exhibited nephritic factor activity that was up to 60 times stronger than that of total
IgG from a patient with
membranoproliferative glomerulonephritis type 2. In addition, anti-C3 NAbs promoted
C3 convertase generation, when added to the convertase precursor or during convertase assembly, suggesting a non-nephritic-factor mechanism. Factors H and I reduced the overall level of activity but had no influence on the NAb dose-response curve meaning that NAbs did not interfere with
factor H binding. Convertase promoting activity during assembly correlated with the content of anti-C3 NAbs in NAb complexes. In conclusion, anti-C3 NAbs associated with framework-specific anti-idiotypic NAbs stabilize
C3 convertase and promote its generation but their activity is compensated for in whole
IgG.